Riskpilot← Back to searchSign inGet full accessClarvin AB
ABDissolvedOrg 5592159759Other research and experimental development on natural sciences and engineering · NACE 7219Est. 201910 employees
Revenue 2022
SEK 17,3M
+22% vs 2021
EBITDA margin
22.0%
-9% vs 2021
Equity ratio
48.1%
Financial strength
Net profit 2022
SEK 3,1M
-6% vs 2021
| Revenue | SEK 17,3M | +22% |
| EBITDA | SEK 3,8M | -9% |
| Net profit | SEK 3,1M | -6% |
| Total assets | SEK 7,6M | -25% |
| Equity | SEK 3,6M | -28% |
| Employees | 10 | — |
Legal name
Clarvin AB
Org number
5592159759
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
26 augusti 2019
Share capital
SEK 50 000
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Dockhorn, David Wilke Firman tecknas i förening av Dockhorn, David Wilke Liljensten, Elisabeth Linnéa
Company purpose
Bolaget ska erbjuda rådgivning till medicintekniska verksamheter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 9 143 | 14 229 | 17 340 |
| Staff expenses | — | — | — |
| EBITDA | 2 529 | 4 199 | 3 816 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 2 529 | 4 199 | 3 816 |
| Net financials | — | 24 | −441 |
| Profit before tax | 2 530 | 4 224 | 3 593 |
| Tax | −865 | −905 | −489 |
| Net profit | 1 665 | 3 319 | 3 104 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total assets | 5 122 | 10 095 | 7 561 |
| Equity | 1 715 | 5 033 | 3 638 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 1 907 | 3 476 | 3 829 |
| Total debt | 1 907 | 3 476 | 3 829 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20202022
Equity ratio
48.1%
This company
38.2%
Market median
+26% vs market
20202022
Return on equity
85.3%
This company
18.4%
Market median
+364% vs market
20202022
Net profit margin
17.9%
This company
8.1%
Market median
+121% vs market
20202022
Asset turnover
2.29×
This company
1.12×
Market median
+104% vs market
20202022
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20202022
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MF Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
TR Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cemba Invest AB
Clarvin AB Board members of Clarvin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Fjellman | Chief Auditor | 0 companies |
| Tord Ragnar Axel Runnäs | Chief Auditor | 0 companies |
| Elisabeth Linnéa Liljensten | Deputy Board Member | 0 companies |
| Göran Henrik Boivie | Deputy Board Member | 0 companies |
| Åsa Helena Runnäs | Board of Directors | 0 companies |
| David Wilke Dockhorn | Chairman | 0 companies |